ConductScience.org, home

Paper1596901

Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage.

Edwards MJ and 5 others. Cancer Res, 1992. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage. Papers, record 1596901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1596901

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage.
PubMed
Journal
Cancer Res
PubMed
Year
1992
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.54
iCite
Revised in PubMed
2006-11-15
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Edwards MJM J
2Miller FNF N
3Sims DED E
4Abney DLD L
5Schuschke DAD A
6Corey TST S

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Capillary PermeabilityMajor topic
Endothelium, VascularMajor topic
Interleukin-2Major topic
NeutrophilsMajor topic
Platelet AdhesivenessMajor topic
Administration, Topical
Animals
Cell Adhesion
Injections, Intravenous
Male
Microcirculation
Microscopy, Electron
Rats
Rats, Inbred Strains

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
40139976Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial data.Immunohorizons2025https://conductscience.org/library/papers/40139976PubMed
39852848Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies.Vaccines (Basel)2025https://conductscience.org/library/papers/39852848PubMed
35360982The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients.Clin Appl Thromb Hemost2022https://conductscience.org/library/papers/35360982PubMed
31073219Safety of low-dose subcutaneous recombinant interleukin-2: systematic review and meta-analysis of randomized controlled trials.Sci Rep2019https://conductscience.org/library/papers/31073219PubMed
28545888Delivering safer immunotherapies for cancer.Adv Drug Deliv Rev2017https://conductscience.org/library/papers/28545888PubMed
24179731Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.Am J Clin Exp Immunol2013https://conductscience.org/library/papers/24179731PubMed
21668966Acute exhaustive exercise regulates IL-2, IL-4 and MyoD in skeletal muscle but not adipose tissue in rats.Lipids Health Dis2011https://conductscience.org/library/papers/21668966PubMed
15627211Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2.Cancer Immunol Immunother2005https://conductscience.org/library/papers/15627211PubMed
8872500Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro.Inflammation1996https://conductscience.org/library/papers/8872500PubMed
7842289Induction of lymphokine-activated killing with reduced secretion of interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma by interleukin-2 analogs.Ann Surg Oncol1994https://conductscience.org/library/papers/7842289PubMed
7712595Eicosanoids and the immunology of cancer.Cancer Metastasis Rev1994https://conductscience.org/library/papers/7712595PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1596901

GET https://conductscience.org/api/papers/v1/1596901/authors